台股 » 個股 » 浩鼎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

浩鼎

(4174)
可現股當沖
  • 股價
    58.7
  • 漲跌
    ▲0.1
  • 漲幅
    +0.17%
  • 成交量
    316
  • 產業
    上櫃 生技醫療類股
  • 218人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
浩鼎 (4174)籌碼相關-永豐金-府城 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-府城 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2019/06/1400.008151.50151.50-8306-2.61%
2019/06/138152.197151.00153.0013120.32%
2019/06/127151.0000.00151.0073192.19%
2019/06/1100.001149.00150.00-1313-0.32%
2019/05/270140.5000.00139.5003540.01%
2019/05/211144.0000.00143.5013870.26%
2019/04/2200.001157.00158.00-1664-0.15%
2019/04/171160.0000.00160.0016760.15%
2019/03/2900.001165.50169.00-1796-0.13%
2019/03/2200.001165.00164.00-1785-0.13%
2019/03/211166.0000.00166.0017860.13%
2019/03/1300.001168.00165.50-1768-0.13%
2019/02/221183.5000.00183.0017710.13%
2019/01/291181.002182.00178.00-1650-0.15%
2019/01/252187.003186.00185.00-1626-0.16%
2019/01/242184.751189.50190.0016010.17%
2019/01/0900.007162.43161.50-7446-1.57%
2019/01/086164.0000.00165.0064371.37%
2019/01/041161.5000.00164.0014230.24%
2019/01/022157.5000.00153.0024010.50%
2018/12/2600.005148.50152.00-5380-1.31%
2018/12/255147.8000.00148.0053701.35%
2018/12/2400.001144.50144.00-1369-0.27%
2018/12/191141.5000.00139.5013890.26%
2018/12/1400.001143.50143.00-1410-0.24%
2018/11/2700.001134.50139.50-1422-0.24%
2018/11/231139.5000.00137.0014120.24%
2018/11/150119.5000.00119.0003910.01%
2018/11/130.1119.5000.00119.500.13900.03%
2018/10/1800.001131.50131.00-1387-0.26%
2018/10/171134.0000.00131.0013880.26%
2018/10/040.2155.0000.00155.000.23660.04%
2018/10/0300.001150.00147.00-1352-0.28%
2018/09/202144.0000.00144.0023200.62%
2018/09/120.2125.0000.00124.500.23060.07%
2018/09/110.1127.0000.00124.000.13100.03%
2018/09/0500.001140.00141.00-1299-0.33%
2018/08/290.1141.5000.00141.500.13180.03%
2018/08/0200.001157.00153.50-1449-0.22%
2018/08/011157.0000.00156.5014500.22%
2018/07/1700.000.2160.00160.50-0.2561-0.04%
2018/07/1600.001161.00160.00-1580-0.17%
2018/07/091157.0000.00157.5016180.16%
2018/06/042168.5000.00167.5028380.24%
2018/06/0100.003172.00172.00-3838-0.36%
2018/05/142161.501162.00162.0018740.11%
2018/05/021169.0000.00169.0019710.10%
2018/04/271163.0000.00162.5019760.10%
2018/04/2000.001183.50181.50-11,094-0.09%
2018/04/1700.001183.50176.50-11,124-0.09%
2018/04/131185.0000.00184.0011,1780.08%
2018/04/1200.003190.00189.00-31,191-0.25%
2018/04/093180.001180.00177.5021,1410.18%
2018/03/301181.5000.00181.5011,1200.09%
2018/03/2700.001173.00173.00-11,098-0.09%
2018/03/2200.008178.00178.00-81,109-0.72%
2018/03/1400.001179.00176.50-11,086-0.09%
2018/03/0900.001175.50174.00-11,088-0.09%
2018/02/2600.001175.00173.00-11,088-0.09%
2018/02/1200.001160.00160.00-11,032-0.10%
2018/02/0700.001161.00160.00-11,020-0.10%
2018/02/062160.7500.00156.5021,0180.20%
2018/01/301182.001182.50183.5009630.00%
2018/01/261179.5000.00181.0019390.11%
2018/01/251170.5000.00169.5019070.11%
2018/01/2400.002170.00169.50-2912-0.22%
2018/01/2300.001.1170.00170.00-1.1921-0.12%
2018/01/175171.6000.00171.0059330.54%
2018/01/166192.081189.50189.5059020.55%
2018/01/1200.002171.00169.00-2808-0.25%
2018/01/102172.0000.00173.0028130.25%
2018/01/092166.000.1165.00166.001.97940.24%
AACR 2024年會 浩鼎將發表ADC藥物臨床前數據Anue鉅亨-2024/03/18
浩鼎乳癌針劑新藥三期臨床期中分析 獲可繼續執行建議Anue鉅亨-2024/01/31
浩鼎新任董座梁賡義:借助官學人脈助公司推動生物統計發展Anue鉅亨-2024/01/22
浩鼎 相關文章